China's Largest Science Park Aims To Double Pharma Output In Three Years; Launches New Partnering Platform
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - The pharmaceutical output of Shanghai Pudong area, where the Zhangjiang Hi-tech park is located, achieved RMB 12.7 billion ($1.85 billion) in 2008 and increased 13.1 percent compared to 2007, said Lin Benchun, the deputy chief of Shanghai Pudong Science and Technology Commission, during the China Pharmaceutical R&D Summit preconference April 6
You may also be interested in...
BIO Welcomes First Chinese Members: Shanghai Zhangjiang Park And Taizhou Medical City
SHANGHAI - BIO, the largest biotechnology organization with 1,200 members around the world, announced its first two members from China - Zhangjiang Hi-tech Park in Shanghai and China Medical City in Taizhou - during the group's annual convention in Chicago
BIO Welcomes First Chinese Members: Shanghai Zhangjiang Park And Taizhou Medical City
SHANGHAI - BIO, the largest biotechnology organization with 1,200 members around the world, announced its first two members from China - Zhangjiang Hi-tech Park in Shanghai and China Medical City in Taizhou - during the group's annual convention in Chicago
Chinese CRO Alliance Sets Eyes On Europe
SHANGHAI - U.K.-based NovaSecta joined Sundia Meditech and HD Biosciences in China's first contract research organization alliance, the three companies announced Feb. 18